This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ferrer Internacional, S.a., Fundacion Centro Nacional De Investigaciones Cardiovasculares Carlos III. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 48 
1 out of 1 Years Active: 2020
Title: Javier Urbano Hurtado: Innovator in Cardiovascular Treatment
Introduction
Javier Urbano Hurtado is a notable inventor based in Sant Cugat del Vallès, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. His innovative approach has led to the development of a unique oral formulation that combines two active agents for enhanced therapeutic efficacy.
Latest Patents
Hurtado holds a patent for an oral formulation aimed at the prevention and treatment of cardiovascular diseases. This invention includes acetylsalicylic acid as the first active agent and an HMG-CoA reductase inhibitor, specifically atorvastatin or rosuvastatin, as the second active agent. The formulation is designed with two or more single separate coated dosage units, featuring a coating that includes water-soluble polymers and a minimal percentage of water-insoluble or enteric polymers. The dosage units are engineered to provide an immediate release profile, showcasing Hurtado's commitment to effective pharmaceutical solutions. He has 1 patent to his name.
Career Highlights
Throughout his career, Javier Urbano Hurtado has worked with prominent organizations such as Ferrer Internacional, S.A. and Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III. His experience in these institutions has allowed him to refine his expertise in cardiovascular research and pharmaceutical development.
Collaborations
Hurtado has collaborated with esteemed colleagues, including Pablo Martin Sanz and Berta Fernández Mollar. These partnerships have contributed to the advancement of his research and the successful development of his patented formulation.
Conclusion
Javier Urbano Hurtado stands out as an innovative inventor in the pharmaceutical industry, particularly in the realm of cardiovascular treatments. His contributions through his patent and collaborations reflect his dedication to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile